NFLX reports Q2 results on June 4 with short sellers holding their positions steady — and the borrow market so loose it barely registers as a constraint. The positioning story is not one of escalating aggression. Short…
POET Technologies opened June with a sharp reversal of the short-covering trend that dominated the prior two weeks — bears are back, and they moved fast. Short interest has rebuilt aggressively. It climbed 39% over the…
FDXF has entered public life as a newly independent LTL trucking company with Wall Street already signalling it has competing views on where the stock goes from here. The setup heading into June is simple but…
Pershing Square Inc. enters June at the intersection of two very different stories — a wave of fresh analyst coverage that spans from cautious to bullish, and a borrow market so expensive it is sending its own…
JBIO heads into its June 9 earnings print with analysts raising targets at an accelerating pace — and the stock ignoring every word of it. The Street's enthusiasm has been unambiguous this week. Three separate target…
OKLO has broken through the ceiling that defined this story for the past month — the stock closed Tuesday at $73.47, clearing the $69–$71 range where its own founders were selling in bulk just five weeks ago, and doing…
INTR is trading at a valuation floor that looks increasingly hard to defend, with the stock down 20% in a month and a fresh UBS buy note doing little to arrest the decline. The most striking tension this week is the…
Enliven Therapeutics enters its June 9 earnings call in an uncomfortable spot: the stock has shed 16.5% over the past week and 15% over the past month, closing at $35.52, while Wall Street has just sharply lifted its…
